Fitch revises India outlook to ‘Stable’, cuts GDP forecast to 7.8% for 2022-23

Spread the love

[ad_1]

Fitch lowered India’s economic growth for 2022/23 to 7.8% from the 8.5% it had forecast in March, saying the inflationary impacts of the global commodity price shock were dampening some of the positive growth momentum.

Fitch Ratings on Friday revised its outlook on India’s long-term foreign currency Issuer Default Rating (IDR) to “Stable” from “Negative,” citing diminished downside risks to medium-term growth.

The ratings agency said risks to the country’s medium-term growth lessened due to rapid economic recovery and easing financial sector weakness, despite near-term headwinds from the global commodity price shock.

“High nominal GDP growth has facilitated a near-term reduction in the debt-to-GDP ratio,” Fitch said in a statement.

Fitch lowered India’s economic growth for 2022/23 to 7.8% from the 8.5% it had forecast in March, saying the inflationary impacts of the global commodity price shock were dampening some of the positive growth momentum.

However, Fitch’s projection was ahead of Reserve Bank of India’s projection of 7.2%.

In 2021/22, India’s economic growth was 8.7%.

Fitch kept its rating of BBB- on India.


Close Story

[ad_2]

Source link

Tags:

7 thoughts on “Fitch revises India outlook to ‘Stable’, cuts GDP forecast to 7.8% for 2022-23

  1. She said that based on these data she would definitely give patients with ADH and LCIS lower doses of tamoxifen, and while she wants to see more data on DCIS patients with further follow up, if I have a DCIS patient who s not tolerating tamoxifen at the 20 mg dose, I d be extremely happy lowering to 5 mg priligy farmacias del ahorro Sugimoto K, Araki N, Ohmori M, et al

  2. Paraovarian cystic endosalpingiosis in association with tamoxifen therapy Working with your doctor to ensure that salt intake is not raising your blood pressure and impacting your heart and kidneys can have a dramatic impact on your health and longevity

  3. cialis 5mg online tumors of low malignant potential are non- invasive, indolent tumors that differ from invasive ovarian cancer in having an excellent prognosis with a five- year survival rate of 95 and occurring more commonly in reproductive- aged women

Leave a Reply

Your email address will not be published. Required fields are marked *